Skip to main content
Clinical Trials/JPRN-UMIN000009643
JPRN-UMIN000009643
Completed
Phase 2

Phase II trial of perioperative chemotherapy with cisplatin and dose dense paclitaxel in patients with stage IB2,IIA2 orIIB uterine cervical cancer SGSG014 - Phase II trial of perioperative dose dense TP in patients with stage IB2,IIA2,IIB uterine cervical cancer (SGSG014)

Sankai Gynecology Study Group0 sites50 target enrollmentDecember 27, 2012

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Cervical cancer patients with clinical stage IB2, IIA, IIB
Sponsor
Sankai Gynecology Study Group
Enrollment
50
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 27, 2012
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Sankai Gynecology Study Group

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Usage of other experimental drugs, phenytoin or flucytosine 2\) History of serious drug allergy or hypersensitivity with cisplatin or paclitaxel 3\) Massive ascites, ileus 4\) Active infection 5\) Peripheral neuropathy grade 2\-4 6\) Unstable angina, myocardinal infarction within 6 months or serious arrthymia 7\) Interstitial pneumonia or fibrosis 8\) Double cancer 9\) No coexisting severe medical conditions such as uncontrollable diabetes mellitus, hypertension or bleeding 10\) Pregnancy or lactation 11\) Mental disease 12\) Continuus usage of steroid 13\) Bilateral hydronephrosis 14\) Judged as inappropriate to participate this trial by investigators

Outcomes

Primary Outcomes

Not specified

Similar Trials